Cadent Capital Advisors’s Clorox CLX Stock Holding History

Cadent Capital Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,129	Closed	-$221K	–	204
2026 Q1	$221K	Buy	2,129 +11	+0.5%	+$1.25K	0.06%	174
2025 Q4	$214K	Buy	2,118 +12	+0.6%	+$1.3K	0.05%	174
2025 Q3	$260K	Buy	+2,106	New	+$261K	0.07%	167

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cadent Capital Advisors's CLX Position: Q2 2026 in Review

Cadent Capital Advisors sold out of Clorox (CLX) in Q2 2026, closing a stake of 2,129 shares — an estimated $221K sold.

Cadent Capital Advisors first reported a position in CLX in Q3 2025 and held it in 3 quarters. The position peaked at $260K in Q3 2025. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Cadent Capital Advisors reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
Cadent Capital Advisors sold 2,129 Clorox shares in Q2 2026, an estimated $221K.
Cadent Capital Advisors first reported a position in Clorox in Q3 2025 and held it in 3 quarters.
Cadent Capital Advisors's Clorox position peaked at $260K in Q3 2025.
1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Cadent Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.